• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CCL
Click for more information
0.00% $13.30

COCA-COLA AMATIL LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CCL
Ann: Update - Dividend/Distribution - CCL 		18/03/19 0 574
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  574 
CCL
News: CCL Coca-Cola Amatil Clarifies Co Is Not Pursuing Bid For Lion Drinks & Dairy Portfolio 		15/03/19 0 155
15/03/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  155 
CCL
Ann: COCA-COLA AMATIL RECENT MEDIA REPORTS 		15/03/19 0 230
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  230 
CCL
Ann: Change of Director's Interest Notice - Alison Watkins 		05/03/19 0 227
05/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  227 
CCL
Ann: 2018 Full Year Results Media Release 		26/02/19 4 1.6K
26/02/19 Last post  Warren10 Comments Created with Sketch.  4  Views Created with Sketch.  1.6K 
CCL
Ann: Dividend/Distribution - CCL 		21/02/19 0 218
21/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  218 
CCL
Ann: 2018 Full Year Results Investor Presentation Pack 		21/02/19 0 140
21/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  140 
CCL
Ann: 2018 Full Year Results & Appendix 4E 		21/02/19 0 123
21/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  123 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.